Amanote Research
Register
Sign In
Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection
Canadian Journal of Gastroenterology
doi 10.1155/2005/378587
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2005
Authors
SI Gan
SM Devlin
NW Scott-Douglas
KW Burak
Publisher
Hindawi Limited
Related search
Lamivudine Treatment Can Restore T Cell Responsiveness in Chronic Hepatitis B.
Journal of Clinical Investigation
Medicine
Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran
Jundishapur Journal of Microbiology
Infectious Diseases
Microbiology
Treatment of Chronic Hepatitis B Virus Infection With Rebavrin.
BMJ
Impact of Lamivudine Plus Adefovir Therapy in Chronic Hepatitis B Iranian Patients, Resistant to Lamivudine Treatment Alone, on Disease Inhibition: A Pilot Study
Open Journal of Gastroenterology
Administration of Lamivudine for Chronic Hepatitis Resulting From Acute HBV Genotype a Infection
Acta Hepatologica Japonica
Hepatology
Effect of Lamivudine Treatment on Survival of 309 North American Patients Awaiting Liver Transplantation for Chronic Hepatitis B
Liver Transplantation
Hepatology
Transplantation
Surgery
Evaluation of Long-Term Entecavir Treatment in Stable Chronic Hepatitis B Patients Switched From Lamivudine Therapy
Hepatology International
Hepatology
Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus
BMJ
Access to Treatment for Hepatitis B Virus Infection-Worldwide, 2016
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
